Literature DB >> 16496361

Re: Correlational of oral tongue cancer inversion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression, by Kim S-H, Cho NH, Kim K, et al.

Megan S Lim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16496361     DOI: 10.1002/jso.20462

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


× No keyword cloud information.
  6 in total

1.  EZB-ICR Cell Line: A New Established and Characterized Oral Squamous Cell Carcinoma Cell Line From Tongue.

Authors:  Nooshafarin Chenari; Bijan Khademi; Mahboobeh Razmkhah
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

2.  The Hannover experience: surgical treatment of tongue cancer--a clinical retrospective evaluation over a 30 years period.

Authors:  Horst Kokemueller; Majeed Rana; Jennifer Rublack; Andre Eckardt; Frank Tavassol; Paul Schumann; Daniel Lindhorst; Martin Ruecker; Nils-Claudius Gellrich
Journal:  Head Neck Oncol       Date:  2011-05-21

3.  Malignant Tumors of Tongue in Iranian Population.

Authors:  Mohammad Esmaeil Akbari; Saede Atarbashi Moghadam; Fazele Atarbashi Moghadam; Zahra Bastani
Journal:  Iran J Cancer Prev       Date:  2016-08-15

4.  GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer.

Authors:  Huan Li; Ling Guo; Shu-Wei Chen; Xiao-Hui Zhao; Shi-Min Zhuang; Li-Ping Wang; Li-Bing Song; Ming Song
Journal:  J Transl Med       Date:  2012-08-20       Impact factor: 5.531

5.  Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication.

Authors:  Tahwinder Upile; Waseem Jerjes; Panagiotis Kafas; Shash Harini; Sandeep U Singh; Marcel Guyer; Melissa Bentley; Holger Sudhoff; Colin Hopper
Journal:  Int Arch Med       Date:  2009-04-24

6.  The anterolateral thigh flap for soft tissue reconstruction in patients with tongue squamous cell carcinoma.

Authors:  Xiang-Juan Tong; Zhan-Gui Tang; Zhen-Feng Shan; Xin-Cheng Guo
Journal:  World J Surg Oncol       Date:  2016-08-12       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.